Details for New Drug Application (NDA): 202572
✉ Email this page to a colleague
The generic ingredient in INDOMETHACIN is indomethacin sodium. There are fifteen drug master file entries for this compound. Additional details are available on the indomethacin sodium profile page.
Summary for 202572
Tradename: | INDOMETHACIN |
Applicant: | Watson Labs Inc |
Ingredient: | indomethacin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202572
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 75MG | ||||
Approval Date: | Dec 9, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription